ATE546450T1 - Microkristall of (e)-8-(3,4-dimethoxystyryl)-1,3- diethyl-7-methyl-3,7-dihydro-1h-purine-2,6-dion - Google Patents

Microkristall of (e)-8-(3,4-dimethoxystyryl)-1,3- diethyl-7-methyl-3,7-dihydro-1h-purine-2,6-dion

Info

Publication number
ATE546450T1
ATE546450T1 AT04731752T AT04731752T ATE546450T1 AT E546450 T1 ATE546450 T1 AT E546450T1 AT 04731752 T AT04731752 T AT 04731752T AT 04731752 T AT04731752 T AT 04731752T AT E546450 T1 ATE546450 T1 AT E546450T1
Authority
AT
Austria
Prior art keywords
dimethoxystyryl
dione
purine
dihydro
diethyl
Prior art date
Application number
AT04731752T
Other languages
English (en)
Inventor
Kazutoshi Kuroda
Noboru Aoki
Toshiro Ochiai
Akihiro Uchida
Yasuhiro Ishikawa
Makoto Kigoshi
Eiji Hayakawa
Kazuki Asanome
Original Assignee
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33432132&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE546450(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd
Application granted granted Critical
Publication of ATE546450T1 publication Critical patent/ATE546450T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT04731752T 2003-05-09 2004-05-07 Microkristall of (e)-8-(3,4-dimethoxystyryl)-1,3- diethyl-7-methyl-3,7-dihydro-1h-purine-2,6-dion ATE546450T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003131417 2003-05-09
PCT/JP2004/006495 WO2004099207A1 (ja) 2003-05-09 2004-05-07 微細結晶

Publications (1)

Publication Number Publication Date
ATE546450T1 true ATE546450T1 (de) 2012-03-15

Family

ID=33432132

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04731752T ATE546450T1 (de) 2003-05-09 2004-05-07 Microkristall of (e)-8-(3,4-dimethoxystyryl)-1,3- diethyl-7-methyl-3,7-dihydro-1h-purine-2,6-dion

Country Status (10)

Country Link
US (1) US7541363B2 (de)
EP (1) EP1626049B1 (de)
JP (2) JP4606326B2 (de)
KR (2) KR20110128216A (de)
CN (1) CN100395245C (de)
AT (1) ATE546450T1 (de)
AU (1) AU2004236101B2 (de)
CA (1) CA2525037C (de)
ES (1) ES2384685T3 (de)
WO (1) WO2004099207A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247639B2 (en) * 2003-06-06 2007-07-24 Endacea, Inc. A1 adenosine receptor antagonists
TW200507882A (en) * 2003-07-17 2005-03-01 Kyowa Hakko Kogyo Kk Solid formulations
JP7382737B2 (ja) * 2019-05-13 2023-11-17 東和薬品株式会社 イストラデフィリン製剤
CN113024558A (zh) * 2021-03-15 2021-06-25 山东新华制药股份有限公司 伊曲茶碱的晶体的制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059091A1 (de) * 1981-02-25 1982-09-01 Leslie Stott Einrichtung zum Regeln der Ausflussmenge
US5484920A (en) 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
JP2928386B2 (ja) * 1992-07-08 1999-08-03 協和醗酵工業株式会社 うつ病治療剤
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
ATE240734T1 (de) * 1995-07-26 2003-06-15 Kyowa Hakko Kogyo Kk Zubereitung von xanthinderivaten als feste dispersion
JPH0940652A (ja) * 1995-07-28 1997-02-10 Kyowa Hakko Kogyo Co Ltd ウラシル誘導体の製造方法
TW200507882A (en) * 2003-07-17 2005-03-01 Kyowa Hakko Kogyo Kk Solid formulations

Also Published As

Publication number Publication date
EP1626049A4 (de) 2008-07-02
AU2004236101A1 (en) 2004-11-18
JP2010195836A (ja) 2010-09-09
KR20110128216A (ko) 2011-11-28
KR101229594B1 (ko) 2013-02-05
EP1626049A1 (de) 2006-02-15
US7541363B2 (en) 2009-06-02
CN100395245C (zh) 2008-06-18
ES2384685T3 (es) 2012-07-11
CN1784405A (zh) 2006-06-07
JPWO2004099207A1 (ja) 2006-07-13
US20060205745A1 (en) 2006-09-14
KR20060015570A (ko) 2006-02-17
JP4606326B2 (ja) 2011-01-05
CA2525037C (en) 2011-12-20
CA2525037A1 (en) 2004-11-18
EP1626049B1 (de) 2012-02-22
WO2004099207A1 (ja) 2004-11-18
AU2004236101B2 (en) 2010-11-11

Similar Documents

Publication Publication Date Title
CA2398887A1 (en) 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
DE502004007000D1 (de) Stickstoff substituierte hexahydro-pyrazino 1,2-a pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2001049688A8 (en) Purine derivatives, process for their preparation and use thereof
WO2004018451A8 (en) Pyridazinone-derivatives as pde4 inhibitors
WO2003041647A3 (en) Synthesis and purification of valacyclovir
ZA200506253B (en) Pyrimidine derivatives for the prevention of HIV infection
PL1613304T3 (pl) Inhibitory DPP-IV
WO2003093269A3 (de) Substituierte pyrazolo-pyrimidin-4-one
MY133479A (en) Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
ATE500254T1 (de) Die replikation von hiv hemmende purinderivate
AU2002357773A1 (en) 1,6 naphthyridines useful as inhibitors of syk kinase
WO2003050087A3 (en) Novel herbicides
WO2005063744A3 (en) IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT
CY1105553T1 (el) Υποκαταστατα 2-πυριμιδινυλιο-6,7,8,9-τετραϋδροπυριμιδο[1,2-α]πυριμιδιν-4-ονιο και 7-πυριμιδινυλιο-2,3-διυδροιμιδαζο[1,2-α]πυριμιδιν-5(1η)ονιο για νευροεκφυλιστικες διαταραχες
WO2006031281A3 (en) Orientation-insensitive ultra-wideband coupling capacitor and method of making
JP2007510401A5 (de)
HK1064096A1 (en) Purine derivatives as a2b adenosine receptor antagonists.
CA2166800A1 (en) 4-substituted piperidine derivatives useful as neurokinin antagonists
ATE472548T1 (de) Substituierte hexahydro-pyrazino(1,2-a)pyrimidin- 4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2001084962A3 (de) Zusammensetzungen enthaltend folsäure und reduziertes folat
WO2003022216A3 (en) Biaryl substituted purine derivatives as potent antiproliferative agents
CA2419665A1 (en) Novel 2-phenylpiperazine derivatives
ATE546450T1 (de) Microkristall of (e)-8-(3,4-dimethoxystyryl)-1,3- diethyl-7-methyl-3,7-dihydro-1h-purine-2,6-dion
WO2002094020A8 (de) Verwendung von triazolopyrimidin-derivaten als mikrobizide im materialschutz
EP1647275A4 (de) Feste pharmazeutische zubereitung